C. A. . WAYHS and T. Von DIEMEN, “Pharmacovigilance Program impact on notifications of adverse reactions to antineoplastic drug in a university hospital”, Rev Bras Farm Hosp Serv Saude, vol. 15, no. 2, p. e1118, Jun. 2024.